Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

6.01

Margin Of Safety %

4

Put/Call OI Ratio

1.03

EPS Next Q Diff

0.14

EPS Last/This Y

0.06

EPS This/Next Y

0.21

Price

58.69

Target Price

69.67

Analyst Recom

1.63

Performance Q

11.49

Relative Volume

1.18

Beta

1.47

Ticker: TECH




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-17TECH58.610.630.0018091
2025-11-18TECH58.160.650.8117818
2025-11-19TECH57.990.655.8617820
2025-11-20TECH58.760.650.0117862
2025-11-21TECH61.520.640.3518119
2025-11-24TECH63.50.520.009704
2025-11-25TECH65.880.540.559461
2025-11-26TECH64.60.550.109393
2025-12-01TECH63.770.550.029422
2025-12-02TECH62.930.550.009520
2025-12-03TECH63.850.550.039524
2025-12-04TECH63.530.552.319533
2025-12-05TECH61.690.561.999567
2025-12-08TECH60.291.360.0123206
2025-12-09TECH58.820.960.1027295
2025-12-10TECH60.830.990.2026928
2025-12-11TECH60.280.990.0426981
2025-12-12TECH58.530.990.1626923
2025-12-15TECH58.71.000.1226848
2025-12-16TECH57.431.030.7326687
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-17TECH58.603.3210.21.98
2025-11-18TECH58.133.3216.11.98
2025-11-19TECH57.813.3216.81.98
2025-11-20TECH58.763.3224.01.98
2025-11-21TECH61.543.3229.81.98
2025-11-24TECH63.493.3224.71.98
2025-11-25TECH65.853.3226.51.98
2025-11-26TECH64.603.3208.41.98
2025-12-01TECH63.753.3210.71.98
2025-12-02TECH62.953.3210.41.98
2025-12-03TECH63.823.3218.91.98
2025-12-04TECH63.523.3213.01.98
2025-12-05TECH61.683.3205.11.98
2025-12-08TECH60.293.3- 1.98
2025-12-09TECH58.823.3206.61.98
2025-12-10TECH60.833.3225.41.98
2025-12-11TECH60.283.3276.91.98
2025-12-12TECH58.503.3269.31.98
2025-12-15TECH58.693.3281.71.98
2025-12-16TECH58.693.1272.21.98
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-17TECH-1.871.174.93
2025-11-18TECH-1.871.174.93
2025-11-19TECH-1.871.174.93
2025-11-20TECH-1.871.174.93
2025-11-21TECH-1.871.174.93
2025-11-24TECH-1.871.324.93
2025-11-25TECH-1.841.324.93
2025-11-26TECH-1.841.326.02
2025-12-01TECH-1.841.446.02
2025-12-02TECH-1.841.446.02
2025-12-03TECH-1.841.446.02
2025-12-04TECH-1.841.446.02
2025-12-05TECH-1.841.446.02
2025-12-08TECH-1.841.386.02
2025-12-09TECH-1.841.386.02
2025-12-10TECH-1.841.386.01
2025-12-11TECH-1.841.386.01
2025-12-12TECH-1.781.386.01
2025-12-15TECH-1.781.386.01
2025-12-16TECH-1.791.386.01
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="TECH" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

0.42

Avg. EPS Est. Current Quarter

0.43

Avg. EPS Est. Next Quarter

0.56

Insider Transactions

-1.79

Institutional Transactions

1.38

Beta

1.47

Average Sales Estimate Current Quarter

290

Average Sales Estimate Next Quarter

321

Fair Value

61.14

Quality Score

79

Growth Score

79

Sentiment Score

33

Actual DrawDown %

56.8

Max Drawdown 5-Year %

-64.8

Target Price

69.67

P/E

117.42

Forward P/E

26.08

PEG

2.59

P/S

7.36

P/B

4.55

P/Free Cash Flow

39.94

EPS

0.49

Average EPS Est. Cur. Y​

1.98

EPS Next Y. (Est.)

2.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

6.41

Relative Volume

1.18

Return on Equity vs Sector %

-23.2

Return on Equity vs Industry %

-8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

272.2
[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”TECH” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”TECH” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”TECH” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”TECH” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”TECH” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”TECH” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”TECH” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Bio-Techne Corp
Sector: Healthcare
Industry: Biotechnology
Employees: 3100
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
stock quote shares TECH – Bio-Techne Corporation Stock Price stock today
news today TECH – Bio-Techne Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch TECH – Bio-Techne Corporation yahoo finance google finance
stock history TECH – Bio-Techne Corporation invest stock market
stock prices TECH premarket after hours
ticker TECH fair value insiders trading